therapeutics
3 articles tagged with ‘therapeutics’
Amyloid Implications in Therapeutics, Bionanomaterials, Biophysics
Researchers highlight challenges in using amyloid structures for drug design due to their sensitivity to environmental conditions. Amyloid fibrils show potential as bionanomaterials like nanowires and gels, but stability issues limit applications. Biophysical studies of amyloid stability require careful validation of analysis assumptions amid structural variability.
Peptide-Antibody Conjugation for Targeted Biologics
Peptide-antibody conjugation combines high-specificity antibodies with functional peptides to create advanced therapeutics and diagnostics. This process addresses limitations like poor tissue penetration and lack of multifunctionality in monoclonal antibodies. Services cover design, synthesis, conjugation, and characterization for biologics development.
Peptide PEGylation: Boosting Stability and Half-Life
Peptide PEGylation attaches polyethylene glycol chains to peptides, improving solubility, extending circulation half-life, reducing degradation, and lowering immunogenicity. This approach addresses key limitations like rapid enzymatic breakdown and short plasma half-life in peptide therapeutics. It supports research from discovery to preclinical stages with precise synthesis and analysis.